Peer Review History

Original SubmissionOctober 30, 2024
Decision Letter - Xiaoshan Zhu, Editor

PONE-D-24-48754

Antidiarrheal, Antidepressant, Hypoglycemic, Analgesic, and Antimicrobial Activities of Methanolic Extract from Sonneratia apetala Fruit, with Identification of Bioactive Compounds in n-Hexane, Chloroform, and Ethyl Acetate Fractions

PLOS ONE

Dear Dr. Uddin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected.

Specifically:

I agree the review that your results� at currrent stage, could not be supportted by the data, more data are necessary. 

I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision.

Kind regards,

Xiaoshan Zhu, Ph.D.

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this manuscript, the authors have investigated the potential medicinal properties of Sonneratia apetala fruit, a mangrove species native to Bangladesh. The study focuses on evaluating the analgesic, antidiarrheal, antidepressant, hypoglycemic, and antimicrobial activities of methanolic extracts from both the pericarp and seed of the fruit. The authors also aim to identify the bioactive compounds present in these extracts.

This research addresses a relevant topic, as the search for novel therapeutic agents from natural sources is crucial, especially with the rise of antimicrobial resistance.

This study employs a comprehensive approach by investigating a wide range of bioactivities, including analgesic, antidiarrheal, antidepressant, hypoglycemic, and antimicrobial effects. This provides a thorough assessment of the fruit's medicinal potential.

The use of standard agents like diclofenac sodium, loperamide, diazepam, and glibenclamide as controls strengthens the validity of the bioactivity assays.

The study also follows ethical guidelines by obtaining approval from the Institutional Animal Ethics Committee.

The use of GC-MS analysis enables the identification of specific bioactive compounds, providing insights into the chemical basis for the observed bioactivities.

However, the manuscript lacks detailed information on the extraction process, such as the solvent-to-sample ratio, extraction time, and the yield of the extracts. This information is crucial for reproducibility and for assessing the efficiency of the extraction method.

The antidepressant activity assessment relies solely on the thiopental sodium-induced sleep time test, which is not a comprehensive measure of antidepressant effects. Including other behavioral tests, such as the forced swim test or tail suspension test, would provide a more robust evaluation of antidepressant potential.

While the antimicrobial activity is assessed against several bacterial and fungal strains, the manuscript doesn't provide the minimum inhibitory concentration (MIC) values, which are essential for determining the potency of the antimicrobial effects

The discussion section could be strengthened by providing more in-depth analysis and comparison of the findings with previous studies on S. apetala and other medicinal plants.

The manuscript would benefit from a more detailed discussion of the potential mechanisms of action of the bioactive compounds identified in the GC-MS analysis. Relating the identified compounds to their potential roles in the observed bioactivities would enhance the scientific significance of the findings

Reviewer #2: The present manuscript contains 30% similarity and 29% AI generated material.

I recommend authors to clear similarity and AI text and re-submit the article.

This manuscript cannot be proceed and published in present form.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: Yes:  Shafi Ullah Khan

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

- - - - -

For journal use only: PONEDEC3

Attachments
Attachment
Submitted filename: article (21).pdf
Attachment
Submitted filename: PONE-D-24-48754_removed (1).pdf
Revision 1

Reviewer #1:

Q1: In this manuscript, the authors have investigated the potential medicinal properties of Sonneratia apetala fruit, a mangrove species native to Bangladesh. The study focuses on evaluating the analgesic, antidiarrheal, antidepressant, hypoglycemic, and antimicrobial activities of methanolic extracts from both the pericarp and seed of the fruit. The authors also aim to identify the bioactive compounds present in these extracts. This research addresses a relevant topic, as the search for novel therapeutic agents from natural sources is crucial, especially with the rise of antimicrobial resistance. This study employs a comprehensive approach by investigating a wide range of bioactivities, including analgesic, antidiarrheal, antidepressant, hypoglycemic, and antimicrobial effects. This provides a thorough assessment of the fruit's medicinal potential. The use of standard agents like diclofenac sodium, loperamide, diazepam, and glibenclamide as controls strengthens the validity of the bioactivity assays. The study also follows ethical guidelines by obtaining approval from the Institutional Animal Ethics Committee.

Response: Thank you for your nice complement.

Q2: The use of GC-MS analysis enables the identification of specific bioactive compounds, providing insights into the chemical basis for the observed bioactivities. However, the manuscript lacks detailed information on the extraction process, such as the solvent-to-sample ratio, extraction time, and the yield of the extracts. This information is crucial for reproducibility and for assessing the efficiency of the extraction method.

Response: Thank you for your nice observation. In the revised manuscript, we have provided the detailed information on the extraction process (Solvent extraction method), such as the solvent-to-sample ratio (10:1), extraction time (72 hr), and the yield of the extracts (10 gm) at sub section 2.3 in LN 118-140.

Q3: The antidepressant activity assessment relies solely on the thiopental sodium-induced sleep time test, which is not a comprehensive measure of antidepressant effects. Including other behavioral tests, such as the forced swim test or tail suspension test, would provide a more robust evaluation of antidepressant potential.

Response: Thank you for your nice query. We perform Central analgesic activity and Peripheral analgesic activity at subsection 2.6 and 2.7 that is why forced swim test or tail suspension test was not performance. In other work, we will try to cover this test more robust evaluation of antidepressant potential.

Q4: While the antimicrobial activity is assessed against several bacterial and fungal strains, the manuscript doesn't provide the minimum inhibitory concentration (MIC) values, which are essential for determining the potency of the antimicrobial effects.

Response: Thank you for your nice suggestion. In the revised manuscript, we have provided the minimum inhibitory concentration (MIC) values of of ciprofloxacin is 0.015 - 2 µg/mL at subsection 2.11 in LN 211.

Q5: The discussion section could be strengthened by providing more in-depth analysis and comparison of the findings with previous studies on S. apetala and other medicinal plants.

Response: Thank you for your nice suggestion. In the revised manuscript, we have provided more in-depth analysis and comparison of the findings with previous studies on S. apetala and other medicinal plants at section 3 in LN 271-274, 303-306, 316-317, 328-330, 354-356, 371-373, and 395-401.

Q6: The manuscript would benefit from a more detailed discussion of the potential mechanisms of action of the bioactive compounds identified in the GC-MS analysis. Relating the identified compounds to their potential roles in the observed bioactivities would enhance the scientific significance of the findings.

Response: Thank you for your nice suggestion. In the revised manuscript we have added detailed discussion of the potential mechanisms of action of the bioactive compounds identified in the GC-MS analysis at LN 475-509 in sub section 3.5.1.

Reviewer #2:

The present manuscript contains 30% similarity and 29% AI generated material.

I recommend authors to clear similarity and AI text and re-submit the article.

This manuscript cannot be proceed and published in present form.

Response: In the revised manuscript, the similarity index is less than 20% according to iThenticate software and 0% according to Turnitin software. All AI-generated material has been removed, and the AI report shows 0%.

Attachments
Attachment
Submitted filename: Reviewer Response.docx
Decision Letter - Hope Onohuean, Editor

Antidiarrheal, Antidepressant, Hypoglycemic, Analgesic, and Antimicrobial Activities of Methanolic Extract from Sonneratia apetala Fruit, with Identification of Bioactive Compounds in n-Hexane, Chloroform, and Ethyl Acetate Fractions

PONE-D-24-48754R1

Dear Dr. Uddin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Hope Onohuean, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Hope Onohuean, Editor

PONE-D-24-48754R1

PLOS ONE

Dear Dr. Uddin,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Hope Onohuean

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .